Filing Flows › Microvision (MVIS) › Q3 2026 › vs Q2 2026
Microvision (MVIS) Q3 2026 vs Q2 2026 (quarter over quarter)
Microvision's revenue rose $927K (+63%) from $1.5M in Q2 2026 to $2.4M in Q3 2026. The biggest changes: Product Revenue +$1.1M (+103%); Contract Revenue −$202K (-57%); License and Royalty Revenue −$6K (-33%).
Microvision, Q3 2026: revenue $2.4M (+896% year over year), operating margin -889.0%, net loss $12.2M, operating cash flow −$13.6M. The chart draws each line against Q2 2026, the increases inside each band.
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Product Revenue | $2.2M | $1.1M | $1.1M | +103% |
| Contract Revenue | $152K | $354K | −$202K | -57% |
| License and Royalty Revenue | $12K | $18K | −$6K | -33% |
| Revenue | $2.4M | $1.5M | $927K | +63% |
| Other income, net | $9.1M | −$12.6M | $21.7M | — |
| Net loss | $12.2M | $36.9M | −$24.7M | -67% |
| Costs & expenses | $23.8M | $38.4M | −$14.6M | -38% |
| Operating costs | $23.7M | $25.7M | −$1.9M | -8% |
| Income tax | $33K | $181K | −$148K | -82% |
| Cost of revenue | $1.2M | $831K | $370K | +45% |
| Research & development | $13.2M | $15.7M | −$2.5M | -16% |
| SG&A | $9.4M | $9.2M | $148K | +2% |
| Operating cash sources | $17.7M | $23.4M | −$5.7M | -24% |
| Depreciation & amortization | $2.9M | $3.0M | −$46K | -2% |
| Share-based compensation | $1.2M | $1.3M | −$142K | -11% |
| Cash used in operations | $13.6M | $19.1M | −$5.5M | -29% |
| Net loss absorbed | $12.2M | $36.9M | −$24.7M | -67% |
| Working capital & other | $5.5M | −$13.5M | $19.0M | — |
Questions
How much did Microvision's revenue grow quarter over quarter in Q3 2026?
Microvision's revenue rose $927K (+63%) from $1.5M in Q2 2026 to $2.4M in Q3 2026.
What drove Microvision's revenue change in Q3 2026?
Product Revenue +$1.1M (+103%); Contract Revenue −$202K (-57%); License and Royalty Revenue −$6K (-33%).